Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities
(Q39971422)
scientific article published in July 2008
scientific article published in July 2008
Language:
Current Data About
Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P50) |
(Q55324938)
|
||||||||||||||||
| (P304) |
2256-2265
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
14
|
||||||||||||||||
| (P478) |
65
|
||||||||||||||||
| (P577) |
Tuesday, July 1, 2008
|
||||||||||||||||
| (P921) |
(Q424771)
|
||||||||||||||||
| (P1433) |
(Q5058352)
|
||||||||||||||||
| (P1476) |
"Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities" (language: en)
|
||||||||||||||||
| (P2093) |
S Meidute Abaraviciene
I Lundquist
|
other details
| description | scientific article published in July 2008 |
External Links
| (P356) |
10.1007/S00018-008-8100-8
|
| (P698) |
18560759
|